Loading component...
Loading component...
Loading component...
Sources: American Cancer Society, American Society of Clinical Oncology, Leukemia and Lymphoma Society, and National Cancer Institute
Sources: American Cancer Society, American Society of Clinical Oncology, Leukemia and Lymphoma Society, and National Cancer Institute
Non-Hodgkin lymphoma is a cancer within the cells of the immune system, specifically the lymphocyte cells (a type of white blood cell) in lymph nodes, spleen, tonsils, digestive tract, thymus (a small organ behind the breastbone), and bone marrow. There are two categories of lymphoma: Hodgkin lymphoma and non-Hodgkin lymphoma. Non-Hodgkin lymphomas can be classified as aggressive (fast-growing) or indolent (slow-growing) cancers depending on the type. There are many different types of non-Hodgkin lymphoma, and researchers have yet to determine a direct cause for the disease. Individuals with severely suppressed immune systems have a higher risk. The survival rate depends on the type and stage of the lymphoma.
The following may be symptoms of non-Hodgkin lymphoma but could be linked to other health conditions. If the following symptoms are present, individuals are encouraged to consult their physician:
There is no known specific prevention for non-Hodgkin lymphoma. Prevention of a weakened immune system is the best way to reduce the risk of non-Hodgkin lymphoma, along with maintaining a healthy body weight.
Treatment options may be tailored based on the type of lymphoma, stage, the patient’s overall health, and potential side effects of therapy. Treatment can include watchful waiting, surgery, chemotherapy, radiation therapy, proton therapy, immunotherapy, targeted therapy, stem cell transplant, and palliative medicine. Physicians including a hematologist, medical oncologist, radiation oncologist, and bone marrow transplant specialist may be part of the medical team, depending on the treatment.